Rare Cancer News & Clinical Trials » Trial - Adenoid Cystic Carcinoma

Feeds

4318 items (4318 unread) in 87 feeds

Acinar Cell Carcinoma (24 unread)

• Google - Acinar Cell Carcinoma (1 unread)
• PubMed - Acinar Cell Carcinoma (23 unread)
• Trial - Acinar Cell Carcinoma

Acinic Cell Carcinoma (33 unread)

• Google - Acinic Cell Carcinoma (1 unread)
• PubMed - Acinic Cell Carcinoma (27 unread)
• Trial - Acinic Cell Carcinoma (5 unread)

Adenoid Cystic Carcinoma (83 unread)

• Google - Adenoid Cystic Carcinoma (19 unread)
• PubMed - Adenoid Cystic Carcinoma (44 unread)
• Trial - Adenoid Cystic Carcinoma (20 unread)

Adrenal Gland Cancer (305 unread)

• Google - Adrenal Cancer (83 unread)
• Google - Adrenocortical Carcinoma (4 unread)
• PubMed - Adrenal Cancer (101 unread)
• PubMed - Adrenocortical Carcinoma (31 unread)
• Trial - Adrenal Cancer (63 unread)
• Trial - Adrenocortical Carcinoma (23 unread)

Ampulla Of Vater (23 unread)

• Google - Ampullary Cancer (1 unread)
• PubMed - Ampullary Cancer (18 unread)
• Trial - Ampullary Carcinoma (4 unread)

Anal Cancer (212 unread)

• Google - Anal Cancer (79 unread)
• PubMed - Anal Cancer (93 unread)
• Trial - Anal Cancers (40 unread)

Angiosarcoma (79 unread)

• Google - Angiosarcoma (11 unread)
• PubMed - Angiosarcoma (57 unread)
• Trial - Angiosarcoma (11 unread)

Appendix Cancer (66 unread)

• Google - Appendix Cancer (9 unread)
• PubMed - Appendix Cancer (42 unread)
• Trial - Appendix Cancer (15 unread)

Bile Duct Cancer (332 unread)

• Google - Bile Duct Cancer (77 unread)
• Google - Cholangiocarcinoma (22 unread)
• PubMed - Bile Duct Cancer (68 unread)
• PubMed - Cholangiocarcinoma (138 unread)
• Trial - Bile Duct Cancer (4 unread)
• Trial - Cholangiocarcinoma (23 unread)

Brain and CNS (1194 unread)

• Google - Rare Brain Tumor (83 unread)
• Google - Rare CNS Tumor (9 unread)
• HemeOncLinx - Neurologic Oncology (29 unread)
• PubMed - Ganglioglioma (14 unread)
• PubMed - Rare Brain Tumor (113 unread)
• PubMed - Rare CNS Tumor (181 unread)
• Trial - Brain Tumor (456 unread)
• Trial - CNS Tumor (309 unread)
• Trial - Ganglioglioma

Carcinoid (124 unread)

• Google - Carcinoid (34 unread)
• PubMed - Carcinoid (48 unread)
• Trials - Carcinoid (42 unread)

Endocrine/Neuroendocrine (500 unread)

• Endocrine Oncology (34 unread)
• Google - Merkel Cell Cancer (50 unread)
• PubMed - Merkel Cell Cancer (51 unread)
• Trial - Merkel Cell Cancer
• Trial - Neuroendocrine Cancers (365 unread)

Gall Bladder Cancer (89 unread)

• Google - Gall Bladder Cancer (25 unread)
• PubMed - Gall Bladder Cancer (63 unread)
• Trials - Gall Bladder Cancer (1 unread)

General (4 unread)

• HemeOncLinx - Alternative Therapies (4 unread)

Hemangioendothelioma (38 unread)

• Google - Hemangioendothelioma (3 unread)
• PubMed - Hemangioendothelioma (32 unread)
• Trial - Hemangioendothelioma (3 unread)

HemeOnc (78 unread)

• Bone/Cartilage (9 unread)
• HemeOncLinx - Side Effects (8 unread)
• Hepatobiliary/Pancreas (30 unread)
• Pain/Palliative Care (14 unread)
• Pediatric Heme/Oncology (17 unread)

Hepatoblastoma (46 unread)

• Google - Hepatoblastoma (17 unread)
• PubMed - Hepatoblastoma (21 unread)
• Trial - Hepatoblastoma (8 unread)

Pancreas (76 unread)

• Google - Insulinoma (5 unread)
• PubMed - Insulinoma (61 unread)
• Trial - Insulinoma (10 unread)

Phyllodes (21 unread)

• Google - Phyllodes Tumor (9 unread)
• PubMed - Phyllodes Tumor (12 unread)
• Trial - Phyllodes

PMP and Mucinous Tumors (35 unread)

• Google - Pseudomyxoma Peritonei (14 unread)
• PubMed - Pseudomyxoma Peritonei (PMP) (21 unread)
• Trial - Pseudomyxoma Peritonei

Rhabdomyosarcoma (175 unread)

• Google - Rhabdomyosarcoma (41 unread)
• PubMed - Rhabdomyosarcoma (75 unread)
• Trial - Rhabdomyosarcoma (59 unread)

Sarcoma (313 unread)

• Google - Sarcoma (63 unread)
• HemeOncLinx - Sarcoma (13 unread)
• PubMed - Sarcoma
• Trial - Sarcoma (237 unread)

Twitter Pals (468 unread)

• Twitter / Bruce_S (99 unread)
• Twitter / childrenscancer (160 unread)
• Twitter / LiftUpEllie (113 unread)
• Twitter / LivingBeyond (34 unread)
• Twitter / MDAndersonNews (41 unread)
• Twitter / vaginal_cancer (21 unread)

Trial - Adenoid Cystic Carcinoma (20 unread)

• 

  Adenoid Cystic Carcinoma, Erbitux, and Particle Therapy

  Posted: August 30th, 2010, 9:00am CDT

  Condition:   Adenoid Cystic Carcinoma
  Intervention:   Drug: cetuximab weekly
  Sponsors:   University of Heidelberg;   Dept. of Radiation Oncology, INF 400, 69120 Heidelberg, Germany;   Heidelberg Ion Therapy Center (HIT), INF 450, 69120 Heidelberg, Germany;   Merck KGaA
  Not yet recruiting - verified August 2010
• 

  Vorinostat in Treating Patients With Locally Advanced, Recurrent, or Metastatic Adenoid Cystic Carcinoma

  Posted: August 4th, 2010, 9:00am CDT

  Condition:   Head and Neck Cancer
  Interventions:   Drug: vorinostat;   Other: laboratory biomarker analysis
  Sponsors:   Barbara Ann Karmanos Cancer Institute;   National Cancer Institute (NCI)
  Not yet recruiting - verified August 2010
• 

  Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid Tumors

  Posted: July 28th, 2010, 9:00am CDT

  Conditions:   Breast Cancer;   Esophageal Cancer;   Gastric Cancer;   Head and Neck Cancer;   Lung Cancer;   Ovarian Cancer;   Prostate Cancer
  Interventions:   Drug: docetaxel;   Drug: pemetrexed disodium
  Sponsors:   University of Arizona;   National Cancer Institute (NCI)
  Recruiting - verified July 2010
• 

  Esophagoscopy in Evaluating Treatment in Patients With Stage I-IV Head and Neck Cancer Who Are Undergoing Radiation Therapy and/or Chemotherapy

  Posted: July 7th, 2010, 9:00am CDT

  Conditions:   Stage I Adenoid Cystic Carcinoma of the Oral Cavity;   Stage I Mucoepidermoid Carcinoma of the Oral Cavity;   Stage I Squamous Cell Carcinoma of the Hypopharynx;   Stage I Squamous Cell Carcinoma of the Larynx;   Stage I Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage I Verrucous Carcinoma of the Larynx;   Stage I Verrucous Carcinoma of the Oral Cavity;   Stage II Adenoid Cystic Carcinoma of the Oral Cavity;   Stage II Mucoepidermoid Carcinoma of the Oral Cavity;   Stage II Squamous Cell Carcinoma of the Hypopharynx;   Stage II Squamous Cell Carcinoma of the Larynx;   Stage II Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage II Verrucous Carcinoma of the Larynx;   Stage II Verrucous Carcinoma of the Oral Cavity;   Stage III Adenoid Cystic Carcinoma of the Oral Cavity;   Stage III Mucoepidermoid Carcinoma of the Oral Cavity;   Stage III Squamous Cell Carcinoma of the Hypopharynx;   Stage III Squamous Cell Carcinoma of the Larynx;   Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage III Verrucous Carcinoma of the Larynx;   Stage III Verrucous Carcinoma of the Oral Cavity;   Stage IV Adenoid Cystic Carcinoma of the Oral Cavity;   Stage IV Mucoepidermoid Carcinoma of the Oral Cavity;   Stage IV Squamous Cell Carcinoma of the Hypopharynx;   Stage IV Squamous Cell Carcinoma of the Larynx;   Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage IV Verrucous Carcinoma of the Larynx;   Stage IV Verrucous Carcinoma of the Oral Cavity
  Interventions:   Procedure: endoscopic procedure;   Other: questionnaire administration
  Sponsor:   Wake Forest University
  Not yet recruiting - verified June 2010
• 

  Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy

  Posted: July 1st, 2010, 9:00am CDT

  Conditions:   Head and Neck Cancer;   Mucositis;   Oral Complications of Radiation Therapy;   Pain
  Interventions:   Drug: doxepin hydrochloride;   Other: placebo
  Sponsors:   North Central Cancer Treatment Group;   National Cancer Institute (NCI)
  Not yet recruiting - verified June 2010
• 

  L-lysine in Treating Oral Mucositis in Patients Undergoing Radiation Therapy With or Without Chemotherapy For Head and Neck Cancer

  Posted: June 29th, 2010, 9:00am CDT

  Conditions:   Mucositis;   Oral Complications of Chemotherapy;   Oral Complications of Radiation Therapy;   Recurrent Adenoid Cystic Carcinoma of the Oral Cavity;   Recurrent Basal Cell Carcinoma of the Lip;   Recurrent Lymphoepithelioma of the Nasopharynx;   Recurrent Lymphoepithelioma of the Oropharynx;   Recurrent Mucoepidermoid Carcinoma of the Oral Cavity;   Recurrent Salivary Gland Cancer;   Recurrent Squamous Cell Carcinoma of the Hypopharynx;   Recurrent Squamous Cell Carcinoma of the Larynx;   Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity;   Recurrent Squamous Cell Carcinoma of the Nasopharynx;   Recurrent Squamous Cell Carcinoma of the Oropharynx;   Recurrent Verrucous Carcinoma of the Larynx;   Recurrent Verrucous Carcinoma of the Oral Cavity;   Stage I Adenoid Cystic Carcinoma of the Oral Cavity;   Stage I Basal Cell Carcinoma of the Lip;   Stage I Lymphoepithelioma of the Nasopharynx;   Stage I Lymphoepithelioma of the Oropharynx;   Stage I Mucoepidermoid Carcinoma of the Oral Cavity;   Stage I Salivary Gland Cancer;   Stage I Squamous Cell Carcinoma of the Hypopharynx;   Stage I Squamous Cell Carcinoma of the Larynx;   Stage I Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage I Squamous Cell Carcinoma of the Nasopharynx;   Stage I Squamous Cell Carcinoma of the Oropharynx;   Stage I Verrucous Carcinoma of the Larynx;   Stage I Verrucous Carcinoma of the Oral Cavity;   Stage II Adenoid Cystic Carcinoma of the Oral Cavity;   Stage II Basal Cell Carcinoma of the Lip;   Stage II Lymphoepithelioma of the Nasopharynx;   Stage II Lymphoepithelioma of the Oropharynx;   Stage II Mucoepidermoid Carcinoma of the Oral Cavity;   Stage II Salivary Gland Cancer;   Stage II Squamous Cell Carcinoma of the Hypopharynx;   Stage II Squamous Cell Carcinoma of the Larynx;   Stage II Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage II Squamous Cell Carcinoma of the Nasopharynx;   Stage II Squamous Cell Carcinoma of the Oropharynx;   Stage II Verrucous Carcinoma of the Larynx;   Stage II Verrucous Carcinoma of the Oral Cavity;   Stage III Adenoid Cystic Carcinoma of the Oral Cavity;   Stage III Basal Cell Carcinoma of the Lip;   Stage III Lymphoepithelioma of the Nasopharynx;   Stage III Lymphoepithelioma of the Oropharynx;   Stage III Mucoepidermoid Carcinoma of the Oral Cavity;   Stage III Salivary Gland Cancer;   Stage III Squamous Cell Carcinoma of the Hypopharynx;   Stage III Squamous Cell Carcinoma of the Larynx;   Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage III Squamous Cell Carcinoma of the Nasopharynx;   Stage III Squamous Cell Carcinoma of the Oropharynx;   Stage III Verrucous Carcinoma of the Larynx;   Stage III Verrucous Carcinoma of the Oral Cavity;   Stage IV Adenoid Cystic Carcinoma of the Oral Cavity;   Stage IV Basal Cell Carcinoma of the Lip;   Stage IV Lymphoepithelioma of the Nasopharynx;   Stage IV Lymphoepithelioma of the Oropharynx;   Stage IV Mucoepidermoid Carcinoma of the Oral Cavity;   Stage IV Salivary Gland Cancer;   Stage IV Squamous Cell Carcinoma of the Hypopharynx;   Stage IV Squamous Cell Carcinoma of the Larynx;   Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage IV Squamous Cell Carcinoma of the Nasopharynx;   Stage IV Squamous Cell Carcinoma of the Oropharynx;   Stage IV Verrucous Carcinoma of the Larynx;   Stage IV Verrucous Carcinoma of the Oral Cavity
  Interventions:   Procedure: quality-of-life assessment;   Procedure: management of therapy complications;   Dietary Supplement: L-lysine
  Sponsor:   Fred Hutchinson Cancer Research Center
  Not yet recruiting - verified June 2010
• 

  Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid Tumor

  Posted: March 30th, 2010, 9:00am CDT

  Conditions:   Breast Cancer;   Cardiovascular Complications;   Colorectal Cancer;   Fallopian Tube Cancer;   Head and Neck Cancer;   Lung Cancer;   Ovarian Cancer;   Peritoneal Cavity Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
  Interventions:   Biological: bevacizumab;   Other: laboratory biomarker analysis;   Other: questionnaire administration;   Procedure: assessment of therapy complications
  Sponsors:   Vanderbilt-Ingram Cancer Center;   National Cancer Institute (NCI)
  Recruiting - verified March 2010
• 

  Nelfinavir in Recurrent Adenoid Cystic Cancer of the Head and Neck

  Posted: February 8th, 2010, 9:00am CST

  Conditions:   Carcinoma, Adenoid Cystic;   Head and Neck Neoplasms
  Intervention:   Drug: Nelfinavir
  Sponsors:   University of Iowa;   Holden Comprehensive Cancer Center
  Recruiting - verified August 2010
• 

  Customized Headrest or Standard Headrest in Holding Patients Still While Undergoing Radiation Therapy for Head and Neck Cancer

  Posted: September 5th, 2009, 9:00am CDT

  Condition:   Head and Neck Cancer
  Interventions:   Other: questionnaire administration;   Radiation: 3-dimensional conformal radiation therapy;   Radiation: radiation therapy treatment planning/simulation
  Sponsor:   All Ireland Cooperative Oncology Research Group
  Active, not recruiting - verified July 2010
• 

  Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial Cancer

  Posted: May 9th, 2009, 9:00am CDT

  Conditions:   Breast Cancer;   Colorectal Cancer;   Head and Neck Cancer;   Lung Cancer;   Prostate Cancer
  Interventions:   Other: laboratory biomarker analysis;   Radiation: radiation therapy
  Sponsor:   Vanderbilt-Ingram Cancer Center
  Completed - verified July 2010
• 

  Collecting and Storing Tissue Samples From Patients With Head and Neck Cancer

  Posted: May 9th, 2009, 9:00am CDT

  Condition:   Head and Neck Cancer
  Interventions:   Other: biologic sample preservation procedure;   Procedure: biopsy
  Sponsors:   Radiation Therapy Oncology Group;   National Cancer Institute (NCI)
  Completed - verified July 2010
• 

  Dasatinib in Treating Patients With Recurrent or Metastatic Malignant Salivary Gland Tumors

  Posted: March 10th, 2009, 9:00am CDT

  Condition:   Head and Neck Cancer
  Interventions:   Drug: dasatinib;   Genetic: gene expression analysis;   Genetic: gene rearrangement analysis;   Genetic: mutation analysis;   Genetic: polymerase chain reaction;   Genetic: polymorphism analysis;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis;   Other: pharmacogenomic studies
  Sponsors:   University of Chicago;   National Cancer Institute (NCI)
  Recruiting - verified July 2010
• 

  Phase II Trial of Doxorubicin and Bortezomib in Patients With Incurable Adenoid Cystic Carcinoma of the Head and Neck

  Posted: December 19th, 2007, 9:00am CST

  Condition:   Adenoid Cystic Carcinoma
  Intervention:   Drug: doxorubicin and bortezomib
  Sponsors:   University of Pittsburgh;   Millennium Pharmaceuticals, Inc.
  Active, not recruiting - verified August 2010
• 

  Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

  Posted: October 1st, 2007, 9:00am CDT

  Condition:   Cancer
  Interventions:   Drug: fentanyl sublingual spray;   Other: questionnaire administration
  Sponsor:   Insys Therapeutics Inc
  Recruiting - verified October 2008
• 

  Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer

  Posted: July 10th, 2007, 9:00am CDT

  Condition:   Cancer
  Interventions:   Drug: cyclophosphamide;   Other: laboratory biomarker analysis;   Procedure: biopsy;   Procedure: cryosurgery
  Sponsors:   Sidney Kimmel Comprehensive Cancer Center;   National Cancer Institute (NCI)
  Recruiting - verified July 2009
• 

  Erlotinib and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer

  Posted: November 8th, 2006, 9:00am CST

  Condition:   Cancer
  Interventions:   Biological: cetuximab;   Drug: erlotinib hydrochloride;   Genetic: proteomic profiling;   Other: laboratory biomarker analysis
  Sponsors:   Vanderbilt-Ingram Cancer Center;   National Cancer Institute (NCI)
  Recruiting - verified January 2009
• 

  NGR-TNF in Treating Patients With Advanced Solid Tumors

  Posted: December 8th, 2004, 9:00am CST

  Conditions:   Colorectal Cancer;   Head and Neck Cancer;   Kidney Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
  Intervention:   Biological: CNGRC peptide-TNF alpha conjugate
  Sponsor:   European Organization for Research and Treatment of Cancer
  Active, not recruiting - verified October 2007
• 

  Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

  Posted: November 12th, 2002, 9:00am CST

  Condition:   Cancer
  Interventions:   Drug: docetaxel;   Drug: thalidomide
  Sponsors:   Case Comprehensive Cancer Center;   National Cancer Institute (NCI)
  Completed - verified June 2010
• 

  Photodynamic Therapy in Treating Patients With Skin Cancer or Solid Tumors Metastatic to the Skin

  Posted: September 13th, 2001, 9:00am CDT

  Conditions:   Breast Cancer;   Head and Neck Cancer;   Lymphoma;   Metastatic Cancer;   Non-melanomatous Skin Cancer;   Sarcoma
  Intervention:   Drug: silicon phthalocyanine 4
  Sponsors:   Case Comprehensive Cancer Center;   National Cancer Institute (NCI)
  Terminated - verified June 2010
• 

  SU5416 and Paclitaxel in Treating Patients With Recurrent, Locally Advanced or Metastatic Cancer of the Head and Neck

  Posted: May 2nd, 2000, 9:00am CDT

  Condition:   Head and Neck Cancer
  Interventions:   Drug: paclitaxel;   Drug: semaxanib
  Sponsors:   Case Comprehensive Cancer Center;   National Cancer Institute (NCI)
  Completed - verified June 2010